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CHAPTER 27 
When Is an Alternative Not an Alternative? 
Supporting Progress for Absolute Replacement 
of Animals in Science 
Craig Redmond 
Lush Prize Management Team, Manchester, United Kingdom 
craig@lushprize.org 
1 Introduction 
Despite a great deal of talk about "alternatives" to animal testing, and "replac­
ing" animal use, there are no clearly agreed upon definitions for these terms. 
This has led to extensive numbers of animals used and accepted as "alterna­
tives"-including zebrafish, invertebrates, animal tissues, embryos, sera, and 
animals' eyes-despite the obvious fact that they will suffer and/or be killed 
for these methods. Instead, there is a confusing array of reference to live ani­
mals, vertebrates, and mammals being termed as "less sentient" or "conscious" 
species. 
Much of the discussion on alternatives is still based around Russell and 
Burch's (1959) 3Rs; although few, if any, of the definitions currently in use 
match their original writings, which were designed to be a foundation for fu­
ture discussions. In the European Union (Eu), Directive 2010/63/EU on the 
protection of animals used for scientific purposes defines its aim as represent­
ing "an important step towards achieving the final goal of full replacement of 
procedures on live animals for scientific and educational purposes, as soon as 
it is scientifically possible to do so" (European Parliament, 2010, Recital 10 ). Al­
though this is a progressive step forward compared to previous legislation, use 
of the word live is often overlooked, as are so many other obstacles to a true end 
to all animal use in laboratory research. Talk of "replacing animal testing" and 
"alternatives" comes with little discussion about what those phrases actually 
mean; while researchers continue to use animal sera, tissues, and live animals 
that are perceived as less sentient. 
This chapter addresses some of the areas in which animals are still used 
within "alternatives" -based research and calls on animal welfare and in vitro or­
ganizations to lead the debate and encourage absolute replacement of animal 
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use in research. Without this, progress to end animal research will always re­
main limited, despite the paradigm shift seen in recent decades. 
2 Russell and Burch 
Russell and Burch's concept of the 3Rs was no doubt radical when their book, 
The Principles of Humane Experimental Technique, was published in 1959 
(hereinafter referred to as The Principles). Alan Goldberg (2010, p. 25), Found­
ing Director of the Center for Alternatives to Animal Testing ( CAAT ), called it, 
"a monumental contribution". A special edition, containing the original text, 
was reissued in 1992; and an abridged version was translated into Mandarin 
and provided to Chinese public libraries and universities for free in 2014. The 
3Rs have also been enshrined into EU legislation on animal experimentation. 
While The Principles has undoubtedly been vital to the discussion on animal 
research over the past 60 years, how relevant is it to the current situation? Has 
the scientific community, which often refers to the 3Rs, actually taken much of 
Russell and Burch's advice on board? These questions are pertinent because, 
as Tannenbaum and Bennett (2015, p. 120) commented, "The Principles was 
presented not as the final word of this science but as a foundation for future 
developments". 
Russell and Burch (1959/1992) defined the 3Rs as replacement: "the substi­
tution for conscious living higher animals of insentient material" ; reduction: 
"reduction in the numbers of animals used to obtain information of a given 
amount and precision" ; and refinement: "any decrease in the incidence or se­
verity of inhumane procedures applied to those animals which still have to be 
used". This chapter focuses on replacement, and how the terms replacement 
and alternatives to animal experimentation are defined across the scientific and 
non-governmental organization sectors. 
3 Replacement: Relative and Absolute 
Russell and Burch defined replacement as "any scientific method employ­
ing non-sentient material" that may replace the use of "conscious living ver­
tebrates". Tannenbaum and Bennett (2015, p. 126) add that replacement, "is 
defined as the use of insentient ( or non-sentient) material instead of sen­
tient material. Russell and Burch do not define replacement as not using 
animals because they classify the use of insentient animals as instances of 
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replacement. They distinguish between what they call relative and absolute 
replacement." 
3.1 Relative Replacement 
"In relative replacement, animals are still required, though [ . . .  ] they are ex­
posed, probably or certainly, to no distress at all. In absolute replacement, 
animals are not required at all at any stage. It follows from what has been said 
earlier that absolute replacement may be regarded as the absolute ideal" (Rus­
sell and Burch, 1959/1992). Relative replacement may include: "non-recovery 
experiments on living and intact but completely anesthetized animals" ; 
"experiments in which animals are still required but only to furnish prepara­
tions after being painlessly killed" ; and "work on the isolated cells, tissues, or 
organs of vertebrates" (Russell and Burch, 1959/1992 ). The Institute for Labora­
tory Animal Research (ILAR) (ILAR, 2011, p. 5) refers to relative replacements as 
"replacing animals such as vertebrates with animals that are lower on the phy­
logenetic scale". ILAR is not unique in its deviation from Russell and Burch's 
definition, as it appears common for species of "lower sentience" to be consid­
ered as (relative) "replacements", without any obvious consideration or discus­
sion of what less sentient means or what evidence it is based on. This is perhaps 
one of the reasons why, in recent years, zebrafish have been promoted as an al­
ternative, as the following example shows: "another 3Rs approach involves the 
replacement of more sentient vertebrates with animals thought to have a low­
er potential for pain perception, such as the amoeba Dictyostelium discoideum, 
fruit fly Drosophila melanogaster and zebrafish" (Tanner and McShane, 20161 
p. 3). The examples that Russell and Burch gave of species they considered 
to be replacements ("the more degenerate metazoan endoparasites") were 
included because they believed "that they are completely non-sentient, not 
because they are less sentient" (Tannenbaum and Bennett, 2015, p. 127 ). 
3.2 Absolute Replacement 
"Turning to absolute replacement, we may distinguish four main subdivi­
sions: the use ( outside the vertebrate body) of metazoan endoparasites; higher 
plants; microorganisms (protozoa, bacteria, molds, etc.); and nonliving physi­
cal and chemical systems. First, there is the study of metazoan endoparasites 
( nematodes, cestodes, and trematodes) in vitro, as opposed to their study in 
the living vertebrate host" (Russell and Burch, 1959/1992). Provisions were still 
made in The Principles for the use of members of the animal kingdom with­
in absolute replacement, whereas the more widely accepted opinion now is 
that no animal or animal-derived material be involved ( Gunatilake, 2016; Lid­
bury and Richardson, 2012 ). The replacement models that have so far been 
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introduced by the scientific community are mostly relative, not absolute, and 
more encouragement needs to be given to progress further in this area. Scien­
tific conferences on alternatives to animal use often seem to focus on reduc­
tion and refinement, with very little discussion on replacement. Michael Balls, 
of the Fund for the Replacement of Animals in Medical Experiments (FRAME) 
noted that, "it is impossible to avoid the conclusion that it [replacement] is 
the forgotten R, even though Russell and Burch saw it as of great importance" 
(2010, p. 21). Balls added that there is "a danger that refinement can be used 
as a convenient way of showing commitment to the 3Rs, whilst ensuring that 
animal experimentation is seen as respectable and can be allowed to continue, 
while the fundamental ethical questions raised by it are avoided". 
4 What Is an Alternative? 
Are "alternatives" and "replacement" the same thing? The United States De­
partment of Agriculture (usoA) (2017) refers to alternatives as "a term that has 
different meanings to different people and this difference largely depends on 
which side of the issue one is found". "Alternatives" are generally based on the 
3Rs, although the terms "alternatives" and "alternative methods" never occur 
in The Principles. The word "alternatives" should be considered to only refer to 
Replacement, yet this is not how it is always viewed. 
The European Union Reference Laboratory for Alternatives to Animal Test­
ing (EURL ECVAM) (2017) defines "alternative" as "generally associated with 
the Principles of the 3Rs [ . . .  ] In this context an alternative method serves to 
fully replace an animal test, to reduce the number of animals needed in a test, 
or to refine an animal testing procedure in order to reduce pain and suffer­
ing." In its "step-by-step approach to an alternatives search," CAAT suggests 
that, in addition to cell culture and tissue culture, researchers "might look 
for non-mammalian animal models-fish or invertebrates, for example­
that would still give you the data you need" (Center for Alternatives to Ani­
mal Testing, n.d. ). However, even using mammals is not always ruled out. 
The UK Government has referred to transgenic mice being used "to replace 
non-human primates" in oral polio vaccine safety tests (Home Office, 2014, 
p. 14). The EU-funded, RETHINK project evaluated the potential for minipigs 
"as an alternative approach" to using dogs and non-human primates in regu­
latory toxicity testing that can contribute to the 3Rs. Although the argument 
was made that this met the criteria for refinement, Forster et al. (2010) noted 
that, "the concept of replacement does not embrace the notion of replacing 
one class of sentient mammal ( e.g. primates) by another ( mini pigs)" (p. 239 ). 
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Others consider a non-animal approach to be one that does not use live ani­
mals (Clippinger et al., 20161 p. 453). AltTox.org (2017), "a website dedicated to 
advancing non-animal methods of toxicity testing" lists "alternative methods" 
for assessing eye irritation/serious eye damage for regulatory testing purposes, 
some of which still use animals, including cow, rabbit, and chicken eyes. 
So, does the term "alternative" apply to any of the 3Rs, all live animals, mam­
mals only, or perhaps just vertebrates? The terms "alternatives to animal test­
ing", as well as "replacement", appear to be used very loosely by stakeholders 
on all sides of the discussion. While the general public are often led to believe, 
or at least not corrected when they do believe, that these terms mean that no 
animal use whatsoever is involved, this is all too often not the case. Philoso­
pher Joel Marks (20121 p. S18) writes that "the so-called alternatives movement 
commonly contains a fatal loophole. For while a layperson may assume that 
the term 'alternative' refers to the use of some wholly nonanimal method of 
research [ . . .  ] in fact, it often means an animal 'down the phylogenetic scale"'. 
Marks believes that, "it is really only full replacement of animals in biomedical 
research that merits the name 'alternative'. Any alternative to that understand­
ing of 'alternatives' is unjustified, not only in word but in deed." (20121 p. S18). 
5 Which Animals Are Protected? 
animal [ . . .  ] a. A living organism which feeds on organic matter, typically 
having specialised sense organs and a nervous system and able to re­
spond rapidly to stimuli; any living creature, including man. [ . . .  ] 
b. In ordinary or non-technical use: any such living organism other than 
a human being. 
Oxford English Dictionary, 2016 
Legislation to protect animals used in laboratory experimentation does not 
protect all animals. Directive 2010/63/EU (European Parliament, 2010 ), the 
key EU legislation relating to animals used for scientific purposes, applies to 
the following animals (Article 1 (3)): "1. (a) live non-human vertebrate ani­
mals, including: (i) independently feeding larval forms; and (ii) foetal forms of 
mammals as from the last third of their normal development; 2. (b) live cepha­
lopods." The Animal Welfare Act (AwA) regulates the use of animals in labo­
ratories in the United States as well as other animal use, including zoos and 
circuses. The term animal in the AWA includes specific species in some, but 
not all, situations and specifically excludes rats of the genus rattus and mice of 
the genus mus as well as birds used in research (USDA, 2017). AWA also excludes 
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cold-blooded animals (fish, reptiles, and amphibians), as well as farmed an­
imals used in agricultural research ( e.g., cows and pigs); as such fewer than 
10% of animals in us laboratories are covered by the AWA (New England Anti­
Vivisection Society, 2017 ). Mice alone make up more than three-quarters of the 
animals used by the top federally-funded us test centers (Kaiser, 2015). Other 
countries have different legislation on what species (if any) are protected in 
experimentation. 
6 ''Alternatives" that Still Exploit Animals 
6.1 Fish 
There has been a greater increase in the use of fish in research in the Eu than 
any other species (European Commission, 2013, p. g). In the United Kingdom, 
fish are the second most used animals after mice (Home Office, 2015, p. 11). 
Zebrafish (Danio rerio) have been the focus of much attention, and they now 
account for 50% of all fish used in UK laboratories, partly due to the avail­
ability of genetically altered zebrafish for use in basic and applied biomedical 
research (Home Office, 2015, p. 23). A major reason for the increase in the use 
of zebrafish is their reduced cost compared to mammals (Reed and Jennings, 
2011, p. 14; maintenance costs are less than 1/1,oooth of the cost for mice); and 
a pair of zebrafish can produce 100-300 eggs per week, making their embryos 
a "suitable model" for high throughput screening (van Vliet, 2011, p. 24). Zebra­
fish have now become established as a "widely accepted relative replacement 
model" (Gunatilake, 2016). 
Researchers at the University of British Columbia reviewed existing litera­
ture on public acceptance of using particular species in laboratories and found 
that fish and invertebrates were "typically rated below mammals, and, as such, 
are often considered an appropriate replacement for mammals in research" 
(Ormandy, Schuppli and Weary, 2012, p. 321). Although their own study found 
that when the research was deemed to cause pain to zebrafish ( specifically 
when it came to ENU mutagenesis) survey participants objected to it (p. 331), it 
may explain why even some in vitro organizations promote the use of zebrafish 
( Gunatilake, Busquet and Akbarsha, 2014; M'Barek et al., 2015 ). Sweeping state­
ments are often made in support of using fish instead of mammals in research, 
with no real attempt to back them up. Planchart et al. (2016, p. 435) claim that, 
"Small freshwater fish models, especially zebrafish, offer advantages over tra­
ditional rodent models, including [ . . .  ] reduced animal welfare concerns". An 
article on the website of the British Association of Zebrafish Husbandry claims 
that, "their mental and physical concerns may be deemed less than those of 
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a rodent for example [ . . .  ] Because of the widespread use of the unprotected 
larval form of zebrafish there is currently little emphasis on replacing aspects 
of this use" (Nicholls, 2012 ). 
In the UK, the Royal Society for the Prevention of Cruelty to Animals 
(RSPCA) has highlighted concerns over zebrafish use in research (Reed and 
Jennings, 2011), including: 
- Specific husbandry requirements are still poorly understood. 
- The majority of experiments, which involve embryonic and early larval (less 
than six days post-hatching) stages, would not be covered and reported by 
legislation. 
- Some practices do not require reporting in the annual Home Office statis­
tics, including the humane killing of zebrafish by an approved method in 
order to obtain tissues, organs, sperm or eggs; and the use of zebrafish in 
breeding programs (unless they are genetically modified). 
Evidence that fish, like all vertebrate animals, feel pain was first presented al­
most 40 years ago (RSPCA, 1980). The UK government's Farm Animal Welfare 
Committee (1996) subsequently acknowledged that fish experience fear, stress, 
and pain when removed from water; and that the physiological mechanisms in 
fish for experiencing pain are very similar to those in mammals. More recently, 
fisheries professor, Victoria Braithwaite (2010) wrote that, "I have argued that 
there is as much evidence that fish feel pain and suffer as there is for birds and 
mammals-and more than there is for human neonates and preterm babies". 
Fish behavior and welfare scientist, Yue Cottee, added (2010) that, "We now 
have logical reason and scientific evidence to start treating fish as sentient crea­
tures" (p. 13); and "it now seems that the question to be asking is not 'Do fish 
have conscious awareness' but 'What is the level and nature of their conscious 
awareness?"' (p. 12). The RSPCA conclude that, ''Although there has been little 
specific study involving zebrafish, given the above [ evidence that fish feel pain] ,  
zebrafish should be given the benefit of any doubt" (Reed and Jennings, 20111 
p. 41). 
6.2 Vertebrates in Early Developmental Stages/Use of Animal Embryos 
Under Directive 2010/63/EU (European Parliament, 2010 ), vertebrates only be­
come protected animals at a particular stage in their development: the last 
third of gestation (mammals); incubation (birds and reptiles); or the stage 
when independent feeding occurs (amphibians and fish), for example, early 
chicken embryos in reproductive toxicity tests. Such cut-off points have been 
criticized as "arbitrary and unsatisfactory" and not based on any strong scien­
tific basis (Balls, 1994, p. 197 ). 
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The fish embryo toxicity (FET) test is considered "a possible alternative to 
the acute fish [toxicity] test" (PETA International Science Consortium, 2015a). 
This test exposes at least seven fish to the test substance for a period of 96 hours 
to record the concentrations that kill 50% of them (LC50) (Organisation for 
Economic Cooperation and Development, OECD, 1992). FET uses 20 freshly­
fertilized embryos per treatment or control (Chemical Watch, 2015), mostly 
zebrafish, fathead minnow, rainbow trout, bluegill, and Medaka. At an interna­
tional symposium on using fish and amphibian embryos as alternative models, 
it was stated that, "In compliance with international animal welfare regula­
tions, the fish and amphibian embryo models provide an ethically acceptable 
small scale analysis system with the complexity of a complete organism [ . . .  ] 
The ultimate goal of the symposium is to promote the development of the fish 
and frog embryo models as potential alternatives to animal testing." (Helm­
holtz Centre for Environmental Research, 2016). A footnote to an article on 
the Chemical Watch website (2015) about FET highlights some of the ongoing 
confusion: "This article was amended on 17 April to clarify that the fish em­
bryo toxicity (FET) test is not considered a replacement to animal testing, as 
fish embryos are animals. However, the use of fish embryos up to a certain age 
does not fall under Directive 2010/63/EU on the protection of animals used for 
scientific purposes." 
6.3 Body Parts 
Animal parts used as "alternatives" to animal testing ( or classed as a "non-animal 
method" (Clippinger et al., 2016), include the eyes of animals slaughtered for 
consumption. Examples are the Bovine Corneal Opacity and Permeability as­
say (BCOP ), seen as a substitute for the Draize eye irritation test that uses live 
rabbits (in which a substance is instilled into one of the rabbit's eyes to as­
sess injury for up to 21 days). The BCOP test method can be used to identify 
chemicals causing serious eye damage. The OECD (Organisation for Economic 
Co-operation and Development, 2017) states that the test "uses isolated cor­
neas from the eyes of cattle slaughtered for commercial purposes, thus avoid­
ing the use of laboratory animals". Along with the isolated chicken eye ( I c E) 
and Isolated Rabbit Eye (IRE) tests, the BCOP assay is validated by regulatory 
bodies, including the OECD and Interagency Coordinating Committee on the 
Validation of Alternative Methods (ICCVAM), as well as promoted by in vitro 
and animal protection organizations (Humane Society International, 2013; 
Institute for In Vitro Sciences, 2014; PETA International Science Consortium, 
2015b ), although again there appears to be no discussion over the ethical con­
siderations of this. 
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6.4 Invertebrates 
Invertebrates are generally exempt from any animal welfare legislation, and 
little consideration is given to their animal care requirements or suitability for 
captive conditions (Carere, Wood and Mather, 2011), with one exception. Since 
2013, all cephalopod species ( e.g., octopus, squid, and cuttlefish) used in re­
search have been regulated within the EU by Directive 2010/63/EU (European 
Parliament, 2010 ), giving them the same legal protection as vertebrates be­
cause of their capacity to experience pain and suffering. Several other non-EU 
countries also regulate their use. Some reviewers believe that decapod crusta­
cea ( e.g., crabs, lobsters) may receive similar protection in the future "because 
of the continuing debate about their pain perception" (Fiorito et al., 2014, p. 15). 
The horseshoe crab, Limulus polyphemus, is used in the Limulus amoebocyte 
lysate (LAL) assay to replace the rabbit pyrogen test for the detection of endo­
toxin in Hepatitis B vaccines (Park et al., 2005). The rabbit test involves inject­
ing the test substance into the ears of three rabbits (wHo, 2016). However, the 
LAL assay uses blood cells from the horseshoe crab, with up to 30% mortality 
due to bleeding (Leschen and Correia, 2010, p. 144 ). 
Russell and Burch (1959/1992) stated that replacement means using com­
pletely insentient material, animal or non-animal. Tannenbaum and Bennett 
( 2015, p. 127) noted that, "using animals that are less sentient [ . . .  ] is inconsistent 
with their definition [ . . .  ] They explicitly argue that, because of more limited 
mental capacities that prevent them from understanding and dealing with dis­
tressful experiences, for lower vertebrates a given level of distress is probably 
worse than it is for a higher vertebrate species." 
6.5 Animal-based Sera 
Fetal calf serum ( also known as fetal bovine serum) is the most widely-used 
serum supplement for in vitro cell culture (Seralab, 2017). Bovine fetal blood is 
collected by cardiac puncture, performed by inserting a needle directly into the 
heart of the unanesthetized fetus in a specially provided area in the slaughter­
house (International Serum Industry Association, 2017 ). Other products are sold 
as a lower cost alternative and for veterinary vaccines, such as horse, goat, rab­
bit, porcine, and chicken serum (Thermo Fisher Scientific, 2017 ). Blood may be 
taken at the time of slaughter for consumption or obtained from what is euphe­
mistically called "donor" animals, from whom blood is taken more than once. 
In a survey of companies and laboratories involved with the collection and 
use of fetal calf serum (Fcs ), Jochems et al. (2002) concluded that: 
- The time that elapses between death of the mother cow and the puncture 
was found to be up to 30 minutes, with the procedure of bleeding itself last­
ing another 2-5 minutes. So, a bleeding procedure may last up to 35 minutes 
after the death of the mother (pp. 4-5). 
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- It is very likely that the fetus is alive at the time of blood collection and "will 
experience pain and/or suffering at the moment of heart puncture for blood 
collection and possibly for a period after that, until it actually dies" (p. 8). 
- "Exsanguination and cardiac puncture (penetrating skin, internal and ex­
ternal intercostal muscles, costal pleura, heart muscle, and heart pleura) 
are both graded as severe discomfort in unanesthetized post-natal bovines. 
From this, we have to conclude that the current practice of blood collection 
from fetal bovines causes suffering to these animals" (p. 11). 
- The global number of bovine fetuses used annually is 1-2 million (p. 5). 
Oredsson (2013), a researcher at Lunds University, stated that, "The very use of 
fetal calf serum actually defeats the purpose of using cell culturing as replace­
ment for animals in research". Jochems et al. (2002, p. 13) similarly argue that, 
"The thought that cell culture techniques requiring FBS are a replacement to 
the use of animals is a misconception." 
6.6 Antibodies 
Traditionally, antibodies against a specified target are produced by injecting 
the antigen into an animal and initiating an immune response (Afability, 2017). 
Animals are repeatedly injected with the molecule to be detected, initiating a 
hyperimmune response. An unknown number of animals (millions) are used 
worldwide to generate the antibodies that are extracted at a later stage for the 
detection of the molecule. Gray et al. (2016) note that, although the extracted 
antibodies are incorporated into an in vitro test, this traditional method is not 
a replacement of animal testing but simply buries the animal use "several lay­
ers deep in the production process, and our ultimate aim, to replace needless 
animal use, is not achieved" (p. 961). Gray and colleagues have called for the 
proper implementation of Directive 2010/63/EU, which requires that animals 
not be used when a non-animal alternative exists. They also recommend that 
the European Union Reference Laboratory for Alternatives to Animal Test­
ing (EURL ECVAM) extends its activities to include the production of animal­
friendly affinity reagents (AFAs) and their subsequent use (p. 967 ). In addition, 
there are reported concerns about the quality and unreliability of commercial, 
animal-derived antibodies ( Groff, Brown and Clippinger, 2015, p. 1788); and sci­
entists are being encouraged to use the non-animal affinity reagents that are 
available. 
6.7 Tissues 
Living material for vertebrate tissue culture has to be obtained from animals 
or humans. Although it may be sourced from animals killed for food (which, 
in itself, is an ethical issue to consider), it is more likely to be obtained from 
animals specifically-bred and killed for the purpose because of requirements, 
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such as a sterile technique (Balls, 1994, p. 197). Data collected for EU Mem­
ber States excludes animals killed solely to supply tissues for ex vivo or in vitro 
use; but for the six countries that Taylor et al. (2008, p. 331) obtained data, the 
average percentage of animals killed for their tissues was 21.1%. Philosopher 
Joel Marks (20121 p. S18) considers it absurd that "the very same animal (both 
species and individual) can be used as an 'alternative'. This is due to two addi­
tional ambiguities. One of them is between an experiment on a whole animal 
and an experiment on tissue taken from an animal of the same species. The 
latter can be considered an 'alternative' but of course the animal is still bred, 
confined, and subject to various procedures". 
7 The Role of Regulatory Bodies in Promoting Animal-based Testing 
It has been shown that "alternatives" to animal testing do not always mean that 
no animals or animal substances are used. Many of the "alternatives" endorsed 
by EURL ECVAM, ICCVAM, and/or the OECD still use animals in some way, for 
example (PETA International Science Consortium, n.d.): 
Rat skin transcutaneous electrical resistance (TER) test for skin corrosion 
Murine local lymph node assay (LLNA) for skin sensitization 
Bovine corneal opacity and permeability (BCOP) test method and Iso­
lated Chicken Eye ( I c E) test method for eye corrosion/ eye irritation 
Whole rat embryo toxicity assay for reproductive toxicity 
FET test and Daphnia sp., acute immobilization test for aquatic toxicity. 
Scientists and organizations working on promoting absolute replacement of 
animal tests need to be proactive in ensuring that regulatory bodies are fully 
aware of these alternatives, and why their validation is preferable to those that 
currently exploit animals. This may involve training regulatory reviewers in the 
new methods. 
A review of companies manufacturing antimicrobial cleaning products to 
discover why so few were submitting non-animal data for regulatory purposes 
(Clippinger et al., 20161 p. 455) found there was a lack of global regulatory ac­
ceptance ( meaning that animal tests would likely be conducted anyway, since 
it was required by other countries or authorities); and uncertainty within in­
dustry about regulatory reviewers' familiarity with the framework and their 
ability to evaluate and interpret non-animal studies, which could influence 
the likelihood of acceptance. The authors concluded that, "Overcoming insti­
tutional inertia at companies and regulatory agencies requires collaboration 
among a motivated group of people across multiple sectors." (p. 455). The mul­
tistep process of implementation includes education of regulatory and indus­
try personnel before a non-animal method is finally accepted. 
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The Lush Prize is an annual prize fund supporting initiatives across science, 
campaigns, and regulatory lobbying to end the use of animals in research, par­
ticularly toxicology. A joint project between Lush Cosmetics and the Ethical 
Consumer Research Association, it provides £250,000 in funding each year in 
the main prize categories, with additional funds provided through regional 
awards in Asia and the Americas (Lush Prize, 2017a ). 
Unique in being a 1R award ( focusing on absolute replacement as opposed 
to 3Rs ), the Lush Prize has strict eligibility guidelines (Lush Prize, 2017b ), 
including: 
- "Non-animal research in this sense means no use of non-human animals (in­
cluding all vertebrates and invertebrates) or primary animal cells, embryos, 
tissues, organs and serums. Human biology-based approaches are strongly 
encouraged, although the use of established cell lines of non-human animal 
origin shall not necessarily be excluded." (Immortalized cell lines can keep 
undergoing division, so no new animals are killed for them). 
- "The prize money shall be ring-fenced for non-animal use so that it cannot 
be used to fund any animal testing whatsoever." 
- "In awarding the prize to academic institutions, priority will be given to re-
search teams or groups which deal exclusively with non-animal research." 
The five categories of prize are designed to complement each other in breaking 
down the barriers to end animal testing. It supports science, so that scientist 
can come up with new tests; training, so that scientists can learn how to use 
the new tests, and young researchers can learn how to discover new tests early 
in their careers; lobbying, so that governments can be persuaded to make the 
new tests compulsory; public awareness, so that the governments can be pres­
sured to make these changes (Lush Prize, 2016). 
In addition to the financial support, the Lush Prize raises the profile of 
absolute replacement through an annual conference and a special edition 
of the Alternatives to Laboratory Animals journal, highlighting the work of 
awarded scientists who are helping to achieve the paradigm shift towards true 
replacement. 
g Conclusions 
Whilst the issue of animal testing is the subject of a great deal of public dis­
course, there has been little discussion about what defines "replacement" or 
"alternatives". Regulatory bodies and many scientists working in "alternatives" 
are not particularly concerned about some of the animal use mentioned here. 
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Their focus, as highlighted in Directive 2010/63/EU (European Parliament, 
2010 ), is the use of live animals. What is of greater concern is the quiet accep­
tance, or even active promotion, of animal-based research by animal welfare 
and in vitro organizations. They should be setting the standards and always 
pushing for absolute replacement; otherwise, progress will remain limited. 
The Lush Prize has begun to put this discussion on the agenda, not only with 
its strict eligibility criteria, but also through its conferences. Its 2014 conference 
was titled, Is One R the new Three Rs?, and asked "Does the consensus building 
around 21st Century Toxicology-a wholly replacement model ( ,R)-mean 
that the 3Rs framework (refinement, reduction, replacement) is an idea that 
has had its day?" (Lush Prize, 2014). There needs to be honesty among regula­
tors and the research community that the use of any animal product is not a 
complete replacement or an alternative, only then can there be encourage­
ment to fully replace animal testing with ethical and reliable human-relevant 
models. 
Russell and Burch's 3Rs have played a crucial role in developing ideas on 
replacing the use of animals in experimentation, and much of what they wrote 
in 1959 is still valid today. However, we need to update the terms "alternative" 
and "replacement" to reflect our goal of completely ending the use of all ani­
mals in research and stop being complacent in thinking that partially replacing 
animal use is sufficient. It will be the role of non-governmental organizations 
and those scientists who truly believe in the goal of complete replacement to 
lead this progression, to agree on definitions and ensure that they begin to be 
used across all sectors, including industry and academia. As Tannenbaum and 
Bennett ( 2015, p. 120) commented, Russell and Burch did not see their writings 
as the final word on this but "a foundation for future developments". 
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